← Back to Patent Explorer
US4647576A Expired / Lapsed US ⏱️ 0.0 years remaining

Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis

Assignee: Warner Lambert Co LLC
•
Filing: 1984-12-10
•
Granted: 1987-03-03
•
Expires: 2004-12-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 6-[2-(Substituted-pyrrol-1-yl)alkyl]pyran-2-ones and the corresponding ring-opened hydroxy-acids derived therefrom are potent inhibitors of the enzyme 3-hydroxy-3-methylglutarylcoenzyme A reductase (HMG-CoA reductase), and are thus useful hypolipidemic and hypocholesterolemic agents. Pharmaceutical compositions containing such compounds, and a method of treatment employing such pharmaceutical compositions are also disclosed.

Inventors

  • 👤 Milton L. Hoefle
  • 👤 Bruce D. Roth
  • 👤 Charlotte D. Stratton

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 12:53
CPC Classifications
C; C07; C07D; C07D405/00; C07D405/02; C07D405/06; C07D407/00; C07D407/02; C07D407/06; C07D487/00; C07D487/02; C07D487/04; C07D491/00; C07D491/02; C07D491/04

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 130 words
A compound having the structural formula ##STR27## wherein X is --CH 2 --, --CH 2 CH 2 --, or --CH(CH 3 )CH 2 --; R 1 is 1-naphthyl, 2-naphthyl, cyclohexyl, norbornenyl, phenyl, phenyl substituted by fluorine, chlorine, hydroxy, trifluoromethyl, alkyl of from one to four carbon atoms, alkoxy of from one to four carbon atoms, alkanoyloxy of from two to eight carbon atoms, 2-, 3-, or 4-pyridinyl, 2-, 3-, or 4-pyridinyl-N-oxide, R 2 and R 3 are independently hydrogen, chlorine, bromine, cyano, trifluoromethyl, phenyl, alkyl of from one to four carbon atoms, carboalkoxy of from two to eight carbon atoms, R 4 is alkyl of from one to four carbon atoms, cyclopropyl, cyclobutyl, or trifluoromethyl; or a corresponding lactone ring-opened dihydroxy acid derived therefrom, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 130 words
A compound having the structural formula ##STR27## wherein X is --CH 2 --, --CH 2 CH 2 --, or --CH(CH 3 )CH 2 --; R 1 is 1-naphthyl, 2-naphthyl, cyclohexyl, norbornenyl, phenyl, phenyl substituted by fluorine, chlorine, hydroxy, trifluoromethyl, alkyl of from one to four carbon atoms, alkoxy of from one to four carbon atoms, alkanoyloxy of from two to eight carbon atoms, 2-, 3-, or 4-pyridinyl, 2-, 3-, or 4-pyridinyl-N-oxide, R 2 and R 3 are independently hydrogen, chlorine, bromine, cyano, trifluoromethyl, phenyl, alkyl of from one to four carbon atoms, carboalkoxy of from two to eight carbon atoms, R 4 is alkyl of from one to four carbon atoms, cyclopropyl, cyclobutyl, or trifluoromethyl; or a corresponding lactone ring-opened dihydroxy acid derived therefrom, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 43 words
A compound in accordance with claim 1 wherein X is --CH 2 CH 2 --; R 1 is as defined in claim 1; R 2 and R 3 are independently hydrogen, chlorine, or bromine; and R 4 is as defined in claim 1.
Claim 4
Dependent Claim 82 words
A compound in accordance with claim 1 wherein X is --CH 2 CH 2 --; R 1 is phenyl, phenyl substituted by fluorine, chlorine, hydroxy, trifluoromethyl, alkyl of from one to four carbon atoms, alkoxy of from one to four carbon atoms, alkanoyloxy of from two to eight carbon atoms, 2-, 3-, or 4-pyridinyl, 2-, 3-, or 4-pyridinyl-N-oxide, R 2 and R 3 are independently hydrogen, chlorine, bromine; and R 4 is alkyl of from one to four carbon atoms, or trifluoromethyl.
Claim 5
Dependent Claim 61 words
A compound in accordance with claim 1 wherein X is --CH 2 CH 2 --; R 1 is phenyl, or phenyl substituted by fluorine, chlorine, hydroxy, trifluoromethyl, alkoxy of from one to four carbon atoms, alkanoyloxy of from two to eight carbon atoms; R 2 and R 3 are independently hydrogen, chlorine, or bromine; and R 4 is isopropyl or trifluoromethyl.
Claim 6
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-6-[2-[3,4-dichloro-2-(4-fluorophenyl)-5-(1-methylethyl)-1H-pyrrol-1-yl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one.
Claim 7
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-6-[2-[3,4-dibromo-2-(4-fluorophenyl)-5-(1-methylethyl)-1H-pyrrol-1-yl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one.
Claim 8
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-6-[2-[2-(4-fluorophenyl)-5-(trifluoromethyl)-1H-pyrrol-1-yl)ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one.
Claim 9
Dependent Claim 12 words
A compound in accordance with claim 1 having the name trans-dimethyl 2-(4-fluorophenyl)-5-(1-methylethyl)-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3,4-dicarboxylate.
Claim 10
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-6-[2-[2-(4-fluorophenyl-5-methyl-1H-pyrrol-1-yl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one.
Claim 11
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-6-[2-[2-(4-fluorophenyl-5-(1-methylethyl)-1H-pyrrol-1-yl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one.
Claim 12
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-6-[2-[2-cyclopropyl-5-(4-fluorophenyl)-1H-pyrrol-1-yl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one.
Claim 13
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-6-[2-[2-(1,1-dimethylethyl)-5-(4-fluorophenyl)-1H-pyrrol-1-yl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one.
Claim 14
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-tetrahydro-4-hydroxy-6-[2-[2-(2-methoxyphenyl)-5-methyl-1H-pyrrol-1-yl]ethyl]-2H-2-one.
Claim 15
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-tetrahydro-4-hydroxy-6-[2-[2-(2-methoxyphenyl)-5-(1-methylethyl)-1H-pyrrol-1-yl]ethyl]-2H-pyran-2-one.
Claim 16
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-tetrahydro-4-hydroxy-6-[2-[2-methyl-5-(1-naphthalenyl)-1H-pyrrol-1-yl]ethyl]-2H-pyran-2-one.
Claim 17
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-6-[2-(2-bicyclo[2.2.1]hep-5-en-2-yl-5-methyl-1H-pyrrol-1-yl)ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one.
Claim 18
Dependent Claim 11 words
A compound in accordance with claim 1 having the name trans-6-[2-[2-(4-fluorophenyl)-5-(1-methylphenyl)-1H-pyrrol-1-yl]propyl]tetrahydro-4-hydroxy-2H-pyran-2-one.
Claim 19
Dependent Claim 28 words
A pharmaceutical composition, useful as a hypocholesterolemic agent, comprising a hypocholesterolemic effective amount of a compound in accordance with claim 1 in combination with a pharmaceutically acceptable carrier.
Claim 20
Dependent Claim 25 words
A method of treating inhibiting cholesterol biosynthesis in a patient in need of such treatment by administering a pharmaceutical composition in accordance with claim 18.

References Cited (Backward Citations)

US3983140A Cited
US4198425A Cited
US4219560A Cited
US4248889A Cited
US4255444A Cited
US4343811A Cited
US4351844A Cited
US4308378A Cited
US4375425A Cited
US4440927A Cited
US4376863A Cited
BE895445A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-03-02 1990-09-01 1991-03-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-03-02 1994-09-01 1995-03-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-03-02 1998-09-01 1999-03-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag